GFAP and Alzheimer disease: In Alzheimer’s disease (AD), for instance, elevated levels of theneuroinflammatory marker Glial fibrillary acidic protein were observed inpreclinical subjects compared to healthy controls, highlighting the role ofneuroinflammation in AD progression [10].